Medication adherence remains an important yet vexing issue in American health care. According to the World Health Organization, medication adherence can have a more direct impact on patient outcomes than a specific treatment itself. Still, it is estimated that a staggering 50% of Americans don’t take their chronic long-term therapy medications as prescribed. Statistics show that each year, poor adherence contributes to more than $500 billion in avoidable health care costs, around 125,000 potentially preventable deaths, and up to 25% of hospitalizations in the United States.  This issue of medication adherence is so important, yet so vexing to solve for because it is so multi-faceted and entrenched into the business economics of healthcare.  In this Race to Value, we must find a better way to ensure affordability and promote adherence to medication therapies.  This is a life or death situation – both from an economic and a clinical perspective.  If we don’t find solutions to improve medication adherence as part of value-based care, patients will die.  And eventually, the weight of the entire healthcare system will collapse upon itself due to the unsustainable costs that are incurred due to avoidable healthcare utilization that medication adherence would have prevented!
Our guest this week is Jason Rose, a leading expert on the trillion dollar impact of the medication adherence issues in our country and what can be done to address them. Since 2018, Jason Rose has been spearheading value-based care as CEO of AdhereHealth. The innovative technology company is focused on transforming healthcare by leveraging intelligent data analytics, promoting medication adherence and working with patients to resolve social determinants of health. Customers are managed care companies and employers looking to improve quality of care and reduce costs for their patients and employees, respectively. After one year in his role, AdhereHealth experienced its fastest-ever year of growth and has grown from about 100 employees to nearly 1,000 employees over the past three years.  This is a leader in the value-based care movement that you should be listening to, as medication adherence is one of the most critical challenges to overcome in the transformation of our industry.
 
Episode Bookmarks:
01:30 According to the World Health Organization, medication adherence can have a more direct impact on patient outcomes than a specific treatment itself.
01:45 50% of Americans don’t take their chronic long-term therapy medications as prescribed.
02:00 Poor adherence contributes to more than $500 billion in avoidable health care costs, causes 125,000 potentially preventable deaths, and up to 25% of hospitalizations.
03:00 Introduction to Jason Rose, a leading expert on medication adherence and CEO ofAdhereHealth.
04:00 Support Race to  Value by subscribing to our weekly newsletter and leaving a review/rating on Apple Podcasts.
06:30 If unabated, medication non-adherence will soon be a trillion-dollar problem with no end in sight.
07:00 Jason discusses the financial impact of non-adherence and the criticality of addressing this issue in healthcare.
08:00 “Medication non-adherence should be one of the top issues in all of healthcare, given the size of the actual problem.”
08:30 How value-based care programs can improve adherence outcomes in both senior and commercial populations.
10:00 A series of factors, rather than a single one, determine patients’ ability to follow treatment recommendations correctly.
11:00 Jason discusses the impact of social determinants of health (SDOH) on medication adherence.
12:00 How SDOH symbolize the “Maslow Hierarchy of Needs for Health Care” (e.g. safe drinking water, transportation, health literacy).
13:00 A critical decision point – paying for the food of a beloved pet instead of purchasing lifesaving medication!
14:00 Referencing Jason’s recent AJMC article: “Medication Adherence is a Force Multiplier for Medicare...

Ver todos los episodios